bioRxiv Science⌕ Search

Biology subjects

Camillo, L. P. d. L.

Publications and source records attributed to Camillo, L. P. d. L..

2 recordsLinked to original sources

Deep Learning-Based Genetic Perturbation Models Do Outperform Uninformative Baselines on Well-Calibrated Metrics

Single cell genetic perturbation modeling involves predicting the effects of unobserved genetic manipulations, enabling scalable in silico screens for target discovery. Recent reports have claimed that deep learning-based perturbation models fail to outperform uninformative baselines, raising doubts about their utility. Here, we show that these conclusions largely stem from limitations of benchmarking metrics, not from the models themselves. We introduce a framework for evaluating bench-mark metric calibration using positive and negative controls, including a new positive control baseline (the interpolated duplicate) and a quantitative calibration measure (the dynamic range fraction). Across 14 perturbation datasets and 13 evaluation metrics, we find that conventional metrics such as mean squared error (MSE) and control-referenced delta correlation (Pearson({Delta}ctrl)) are often poorly calibrated, whereas weighted and rank-based alternatives exhibit consistent calibration. Under well-calibrated metrics, deep learning models outperform mean, control, and linear baselines, and in some cases even surpass the additive baseline in combination-prediction tasks. Calibrated evaluation thus explains prior reports of model underperformance, revealing that deep learning models do outperform uninformative baselines.

bioinformatics↗

An Open Competition for Biomarkers of Aging

Open scientific competitions have successfully driven biomedical advances but remain underutilized in aging research, where biological complexity and heterogeneity require methodological innovations. Here, we present the results from Phase I of the Biomarkers of Aging Challenge, an open competition designed to drive innovation in aging biomarker development and validation. The challenge leverages a unique DNA methylation dataset and aging outcomes from 500 individuals, aged 18 to 99. Participants are asked to develop novel models to predict chronological age, mortality, and multi-morbidity. Results from the chronological age prediction phase show important advances in biomarker accuracy and innovation compared to existing models. The winning models feature improved predictive power and employ advanced machine learning techniques, innovative data preprocessing, and the integration of biological knowledge. These approaches have led to the identification of novel age-associated methylation sites and patterns. This challenge establishes a paradigm for collaborative aging biomarker development, potentially accelerating the discovery of clinically relevant predictors of aging-related outcomes. This supports personalized medicine, clinical trial design, and the broader field of geroscience, paving the way for more targeted and effective longevity interventions.

bioinformatics↗